Jiang Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiang Zheng has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Liang Zhang
Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China
3 shared publicationsBin Tian
Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China
2 shared publicationsRuipu Zhang
Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China
2 shared publicationsXin Kang
Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China
2 shared publicationsYiqun Wang
Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China
2 shared publicationsAiyong Cui
Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (2) , 1-18
Metabolic messengers from the gut to the joint: Toward precision management of osteoarthritis (Review)
Osteoarthritis has evolved from a mechanical concept to a metabolic whole‑organ disease driven by systemic inflammation. The 'gut‑joint axis' represents a 'biological highway' where intestinal dysbiosis permits the translocation of microbial metabolites into synovial joints. This review focuses on three pivotal metabolite classes with opposing roles: Short‑chain fatty acids (SCFAs), which function as anti‑inflammatory guardians; trimethylamine N‑oxide (TMAO), which acts as a pro‑inflammatory aggressor; and bile acids (BAs), which serve as complex regulators that balance homeostasis and catabolism. This review further proposes a novel 'metabolite homeostasis imbalance' theoretical framework, which posits that osteoarthritis pathogenesis is driven by the disruption of the dynamic equilibrium between protective (SCFAs), destructive (TMAO) and context‑dependent regulatory (BAs) microbial metabolites. This integrative 'metabolite homeostasis imbalance' model deconstructs the 'biological highway' metaphor into a three‑tier mechanistic schema encompassing intestinal barrier integrity, systemic metabolite trafficking and tissue‑specific effector functions in the joint microenvironment, thereby providing a unifying conceptual foundation bridging scattered single‑metabolite research and mechanism‑targeted precision OA management. Additionally, the potential of sports medicine interventions, including exercise and probiotics, to modulate this axis is evaluated. This synthesis provides a comprehensive theoretical basis for novel clinical strategies targeting gut‑derived metabolic networks to preserve joint health and mitigate disease progression.
- 22 June 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (2) , 1-18
Open AccessMetabolic messengers from the gut to the joint: Toward precision management of osteoarthritis (Review)
Osteoarthritis has evolved from a mechanical concept to a metabolic whole‑organ disease driven by systemic inflammation. The 'gut‑joint axis' represents a 'biological highway' where intestinal dysbiosis permits the translocation of microbial metabolites into synovial joints. This review focuses on three pivotal metabolite classes with opposing roles: Short‑chain fatty acids (SCFAs), which function as anti‑inflammatory guardians; trimethylamine N‑oxide (TMAO), which acts as a pro‑inflammatory aggressor; and bile acids (BAs), which serve as complex regulators that balance homeostasis and catabolism. This review further proposes a novel 'metabolite homeostasis imbalance' theoretical framework, which posits that osteoarthritis pathogenesis is driven by the disruption of the dynamic equilibrium between protective (SCFAs), destructive (TMAO) and context‑dependent regulatory (BAs) microbial metabolites. This integrative 'metabolite homeostasis imbalance' model deconstructs the 'biological highway' metaphor into a three‑tier mechanistic schema encompassing intestinal barrier integrity, systemic metabolite trafficking and tissue‑specific effector functions in the joint microenvironment, thereby providing a unifying conceptual foundation bridging scattered single‑metabolite research and mechanism‑targeted precision OA management. Additionally, the potential of sports medicine interventions, including exercise and probiotics, to modulate this axis is evaluated. This synthesis provides a comprehensive theoretical basis for novel clinical strategies targeting gut‑derived metabolic networks to preserve joint health and mitigate disease progression.
- Open Access
- 31 October 2025
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 33 (1) , 1-11
The gut‑bone‑cartilage triad: Microbial regulation of the Wnt/β‑catenin signaling pathway in osteoarthritis joint remodeling (Review)
Osteoarthritis (OA) is a prevalent chronic joint disorder with a notable global health burden, characterized by articular cartilage degeneration, abnormal bone remodeling and synovial inflammation. Traditional treatments mainly focus on symptom management rather than addressing the underlying disease mechanisms. The gut microbiome serves a potential role in OA through the gut‑bone‑cartilage axis. Notably, the gut microbiome and its metabolites can influence bone and cartilage homeostasis, and the Wnt/β‑catenin signaling pathway has been implicated in OA pathogenesis. The present study comprehensively reviews the emerging evidence supporting the gut‑bone‑cartilage axis in OA and the role of microbial regulation of Wnt/β‑catenin signaling in joint remodeling. The current understanding of the influence of the gut microbiome on OA pathogenesis is summarized, discussing the mechanisms underlying the gut‑bone‑cartilage axis and exploring the therapeutic potential of targeting this axis. Future research should focus on developing targeted therapies that modulate the gut microbiome and the Wnt/β‑catenin pathway, as well as exploring the potential of gene editing and carrier technologies for OA treatment.
- 31 October 2025
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 33 (1) , 1-11
Open AccessThe gut‑bone‑cartilage triad: Microbial regulation of the Wnt/β‑catenin signaling pathway in osteoarthritis joint remodeling (Review)
Osteoarthritis (OA) is a prevalent chronic joint disorder with a notable global health burden, characterized by articular cartilage degeneration, abnormal bone remodeling and synovial inflammation. Traditional treatments mainly focus on symptom management rather than addressing the underlying disease mechanisms. The gut microbiome serves a potential role in OA through the gut‑bone‑cartilage axis. Notably, the gut microbiome and its metabolites can influence bone and cartilage homeostasis, and the Wnt/β‑catenin signaling pathway has been implicated in OA pathogenesis. The present study comprehensively reviews the emerging evidence supporting the gut‑bone‑cartilage axis in OA and the role of microbial regulation of Wnt/β‑catenin signaling in joint remodeling. The current understanding of the influence of the gut microbiome on OA pathogenesis is summarized, discussing the mechanisms underlying the gut‑bone‑cartilage axis and exploring the therapeutic potential of targeting this axis. Future research should focus on developing targeted therapies that modulate the gut microbiome and the Wnt/β‑catenin pathway, as well as exploring the potential of gene editing and carrier technologies for OA treatment.
- Top Cited PapersOpen Access
- 3 October 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 965376
Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018
Background: The National Health and Nutrition Examination Surveys (NHANES) collect and release data to the public every 2 years. The latest NHANES study on the vitamin D status of Americans was based on data from 2001 to 2014, and the latest data (2015–2016 and 2017–2018) have not been studied yet. Thus, we extracted all the available data from NHANES (2001–2018), aiming to analyze the prevalence and trends of vitamin D deficiency (VDD) in the US population to bridge the research gap.Methods: According to previous studies and nutritional guidelines for vitamin D, severe VDD was defined as serum 25(OH)D levels of 75 nmol/L. We comprehensively estimated the prevalence of serum 25(OH)D levels of 75 nmol/L in Americans and described trends in vitamin D status from 2001 to 2018. Weighted multivariate linear regression models were used to explore the predictors of VDD. All analyses and the data were adjusted for the complex sampling design of NHANES using Mobile Examination Center (MEC) weights.Results: Based on the most recent data of 71,685 participants, our study showed that the weighted prevalence of severe and moderate VDD was 2.6% and 22.0%, and the prevalence of vitamin D insufficiency (VDI) and sufficiency was 40.9% and 34.5%. The prevalence of severe and moderate VDD was higher in women, non-Hispanic black Americans, people aged 20–29 years, and during the season of winter. From 2001 to 2018, we found a slight linear decrease in the prevalence of moderate VDD (coefficient = −0.847; P = 0.009) and VDI (coefficient = −0.810; P = 0.014). We also found a slight linear increase in vitamin D sufficient (coefficient = 1.693; P = 0.004). However, no trend change was observed in severe VDD (coefficient = −0.037; P = 0.698). Age, sex, ethnicity, season, sun-protective behaviors, lower BMI, lower socioeconomic status (SES), drinking, and lower milk consumption were predictors of severe VDD.Conclusion: Vitamin D deficiency is still prevalent in the United States, especially in non-Hispanic black Americans, women, individuals aged 20–29, and during winter. Therefore, individuals, healthcare providers, and policymakers should take public health measures to develop and implement prevention strategies to deal with VDD.
- 3 October 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 965376
Top Cited PapersOpen AccessPrevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018
Background: The National Health and Nutrition Examination Surveys (NHANES) collect and release data to the public every 2 years. The latest NHANES study on the vitamin D status of Americans was based on data from 2001 to 2014, and the latest data (2015–2016 and 2017–2018) have not been studied yet. Thus, we extracted all the available data from NHANES (2001–2018), aiming to analyze the prevalence and trends of vitamin D deficiency (VDD) in the US population to bridge the research gap.Methods: According to previous studies and nutritional guidelines for vitamin D, severe VDD was defined as serum 25(OH)D levels of 75 nmol/L. We comprehensively estimated the prevalence of serum 25(OH)D levels of 75 nmol/L in Americans and described trends in vitamin D status from 2001 to 2018. Weighted multivariate linear regression models were used to explore the predictors of VDD. All analyses and the data were adjusted for the complex sampling design of NHANES using Mobile Examination Center (MEC) weights.Results: Based on the most recent data of 71,685 participants, our study showed that the weighted prevalence of severe and moderate VDD was 2.6% and 22.0%, and the prevalence of vitamin D insufficiency (VDI) and sufficiency was 40.9% and 34.5%. The prevalence of severe and moderate VDD was higher in women, non-Hispanic black Americans, people aged 20–29 years, and during the season of winter. From 2001 to 2018, we found a slight linear decrease in the prevalence of moderate VDD (coefficient = −0.847; P = 0.009) and VDI (coefficient = −0.810; P = 0.014). We also found a slight linear increase in vitamin D sufficient (coefficient = 1.693; P = 0.004). However, no trend change was observed in severe VDD (coefficient = −0.037; P = 0.698). Age, sex, ethnicity, season, sun-protective behaviors, lower BMI, lower socioeconomic status (SES), drinking, and lower milk consumption were predictors of severe VDD.Conclusion: Vitamin D deficiency is still prevalent in the United States, especially in non-Hispanic black Americans, women, individuals aged 20–29, and during winter. Therefore, individuals, healthcare providers, and policymakers should take public health measures to develop and implement prevention strategies to deal with VDD.
- 1 August 2020
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 24 (8) , 460-466
Association Between Genetic Polymorphisms of CR2 Gene and the Risk of Steroid-Induced Osteonecrosis of the Femoral Head in the Chinese Han Male Population
Background: Multiple lines of evidence have suggested that genetic factors may contribute to steroid-induced osteonecrosis of the femoral head (SONFH). Complement receptor 2 (CR2), constituting a family of regulators of complement activation, has been recently reported to be associated with osteonecrosis of the femoral head (ONFH) in Koreans. The aim of this study was to evaluate the relationships between the CR2 gene and susceptibility to SONFH in the male Han Chinese population. Materials and Methods: A total of 468 SONFH patients and 1224 healthy controls were recruited to the study. Ten tag single nucleotide polymorphisms (SNPs) located within the CR2 gene were genotyped. Genetic association analyses, including SNP and haplotypic analyses, were performed for the 10 SNPs. Furthermore, bioinformatic analyses were conducted to examine the functional consequences of significant SNPs. Results: An intronic SNP, rs311306, was identified to be significantly associated with the risk of SONFH (p = 0.0008, odds ratio = 1.44). Allelic analyses showed that the C allele of this SNP significantly elevated the risk of SONFH, which was replicated in genotypic association analyses. Moreover, a 3-SNP haplotype was significantly associated with SONFH (rs311306–rs17044576–rs3767933, p = 7.49 × 10−8). Furthermore, bioinformatic analysis results indicated limited functional consequences of SNP rs311306, but a complex interaction network was constructed by the protein encoded by the SLC44A2 gene and proteins encoded by CD19, CD81, and C3 genes. Conclusion: Our findings shed new light on the link between the CR2 gene and SONFH in Han Chinese males, providing clues as to the nature of the mechanisms involved in the etiology of ONFH.
- 1 August 2020
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 24 (8) , 460-466
Association Between Genetic Polymorphisms of CR2 Gene and the Risk of Steroid-Induced Osteonecrosis of the Femoral Head in the Chinese Han Male Population
Background: Multiple lines of evidence have suggested that genetic factors may contribute to steroid-induced osteonecrosis of the femoral head (SONFH). Complement receptor 2 (CR2), constituting a family of regulators of complement activation, has been recently reported to be associated with osteonecrosis of the femoral head (ONFH) in Koreans. The aim of this study was to evaluate the relationships between the CR2 gene and susceptibility to SONFH in the male Han Chinese population. Materials and Methods: A total of 468 SONFH patients and 1224 healthy controls were recruited to the study. Ten tag single nucleotide polymorphisms (SNPs) located within the CR2 gene were genotyped. Genetic association analyses, including SNP and haplotypic analyses, were performed for the 10 SNPs. Furthermore, bioinformatic analyses were conducted to examine the functional consequences of significant SNPs. Results: An intronic SNP, rs311306, was identified to be significantly associated with the risk of SONFH (p = 0.0008, odds ratio = 1.44). Allelic analyses showed that the C allele of this SNP significantly elevated the risk of SONFH, which was replicated in genotypic association analyses. Moreover, a 3-SNP haplotype was significantly associated with SONFH (rs311306–rs17044576–rs3767933, p = 7.49 × 10−8). Furthermore, bioinformatic analysis results indicated limited functional consequences of SNP rs311306, but a complex interaction network was constructed by the protein encoded by the SLC44A2 gene and proteins encoded by CD19, CD81, and C3 genes. Conclusion: Our findings shed new light on the link between the CR2 gene and SONFH in Han Chinese males, providing clues as to the nature of the mechanisms involved in the etiology of ONFH.
- 1 August 2019
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 139 (11) , 1617-1624
Isolated trochleoplasty for recurrent patellar dislocation has lower outcome and higher residual instability compared with combined MPFL and trochleoplasty: a systematic review
To identify the efficacy of isolated trochleoplasty (TP) as an independent treatment for severe trochlear dysplasia compared with TP combined with medial patellofemoral ligament (MPFL) reconstruction. Search of current literature using terms (trochleoplasty and medial patellofemoral ligament reconstruction) in the electronic search engines PubMed and Embase, and Medline databases was performed on February 25, 2018, and it yielded 515 abstracts for review. At the end of the search, six articles met specific inclusion criteria and were included in this review. Means were calculated for population size, age and follow-up time. The Kujala score was analyzed as the primary clinical outcome parameter in the meta-analysis. Pooled estimates were calculated for postoperative complications. Six studies with a total of 192 knees (168 patients) were included in this analysis. The isolated TP group comprised of 3 articles with a total of 111 knees, and the TP combined with MPFL group comprised of 3 articles with a total of 81 knees. At the final follow-up, the preoperative Kujala score increased significantly by 21.39 (95% CI 18.94, 23.84; P < 0.00001) points in the isolated TP group and by 24.91 (95% CI 15.47, 34.36; P < 0.00001) points in the TP combined with MPFL group. The rates of subjective patellar instability including subluxation and anterior knee pain were 1.03% and8.45% respectively. Meanwhile, the rate of objective patellar redislocation was 2.06% in isolated TP group and 0% in TP combined with MFPL group. A total of 8.24% returned to the operating room for additional procedures in the isolated TP group and 7.04% in the TP combined with MPFL group. Trochleoplasty is a useful and reliable surgical technique to improve patellofemoral instability in patients with a dysplastic trochlea. However, it as isolated treatment for patients has lower outcome and higher residual instability compared with combined MPFL and trochleoplasty.
- 1 August 2019
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 139 (11) , 1617-1624
Isolated trochleoplasty for recurrent patellar dislocation has lower outcome and higher residual instability compared with combined MPFL and trochleoplasty: a systematic review
To identify the efficacy of isolated trochleoplasty (TP) as an independent treatment for severe trochlear dysplasia compared with TP combined with medial patellofemoral ligament (MPFL) reconstruction. Search of current literature using terms (trochleoplasty and medial patellofemoral ligament reconstruction) in the electronic search engines PubMed and Embase, and Medline databases was performed on February 25, 2018, and it yielded 515 abstracts for review. At the end of the search, six articles met specific inclusion criteria and were included in this review. Means were calculated for population size, age and follow-up time. The Kujala score was analyzed as the primary clinical outcome parameter in the meta-analysis. Pooled estimates were calculated for postoperative complications. Six studies with a total of 192 knees (168 patients) were included in this analysis. The isolated TP group comprised of 3 articles with a total of 111 knees, and the TP combined with MPFL group comprised of 3 articles with a total of 81 knees. At the final follow-up, the preoperative Kujala score increased significantly by 21.39 (95% CI 18.94, 23.84; P < 0.00001) points in the isolated TP group and by 24.91 (95% CI 15.47, 34.36; P < 0.00001) points in the TP combined with MPFL group. The rates of subjective patellar instability including subluxation and anterior knee pain were 1.03% and8.45% respectively. Meanwhile, the rate of objective patellar redislocation was 2.06% in isolated TP group and 0% in TP combined with MFPL group. A total of 8.24% returned to the operating room for additional procedures in the isolated TP group and 7.04% in the TP combined with MPFL group. Trochleoplasty is a useful and reliable surgical technique to improve patellofemoral instability in patients with a dysplastic trochlea. However, it as isolated treatment for patients has lower outcome and higher residual instability compared with combined MPFL and trochleoplasty.